What is the LPA gene?
Apolipoprotein(a) locus controlling circulating lipoprotein(a) concentration.
How LPA affects metabolism
When LPA-related function is shifted, the practical effect is interpreted through lipoprotein transport, triglyceride-rich particles, LDL clearance, or liver lipid handling. This does not mean the pathway is active or impaired right now; it means the gene can help prioritize what to check next.
What happens when LPA is altered
Altered LPA signal should be treated as a DNA-based tendency, not a diagnosis. 2 claims currently pass the report-use gate. The useful question is whether symptoms, labs, and lifestyle context line up with the pathway signal.
Curated SNP evidence for LPA
These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.
Evidence-backed report connection
LPA currently has 2 curated SNPs, 2 claim-level scores, and 2 claims eligible for pathway scoring.
Open the sample reportrs10455872LPA rs104558721 claims · 2 study rows
biomarker tendency · G
lipoprotein(a) concentration tendency
rs10455872 G at the LPA locus is associated with higher circulating lipoprotein(a) concentration tendency.
LPA rs10455872 G is staged as a higher Lp(a) concentration allele.
Show study evidence
rs3798220LPA I4399M1 claims · 2 study rows
biomarker tendency · C carrier
Lipoprotein(a) biomarker tendency
rs3798220 C / LPA I4399M carrier status is associated with higher plasma lipoprotein(a) and oxidized phospholipid-bearing Lp(a) tendency.
LPA rs3798220 C is staged as a lipid-pathway marker for higher Lp(a)-related particle burden.
Show study evidence
Common symptoms people report
- unexpected cholesterol or triglyceride results
- family context around lipid markers
- unclear ApoB, LDL-C, HDL-C, or triglyceride patterns
Biomarkers to validate
ApoB
Shows the number of atherogenic particles more directly than total cholesterol.
LDL-C, HDL-C, and triglycerides
Gives the basic lipid pattern that DNA can help contextualize.
Lp(a) or liver enzymes when relevant
Adds context for inherited lipid risk or liver lipid handling.
Where DNA analysis helps
DNA helps decide whether LPA deserves attention inside the broader Lipids pathway. It is most useful when combined with biomarkers instead of used as a standalone answer.
Example interpretation
LPA may add context to lipoprotein transport, triglyceride-rich particles, LDL clearance, or liver lipid handling, especially when its SNP evidence lines up with other genes in the same pathway.
Suggested validation: ApoB.
What to do next
- Review the Lipids pathway result before interpreting LPA on its own.
- Use relevant biomarkers to confirm whether this DNA tendency is visible in current biology.
- Treat supplement or nutrition decisions as follow-up steps only after the pattern fits symptoms or labs.
Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.
Get My DNA Report